Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Filing Date
Apr 21, 2021
Document Date
Jun 1, 2021
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/